ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 86 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,596 | -15.7% | 4,610 | 0.0% | 0.00% | – |
| Q2 2023 | $4,264 | +42.1% | 4,610 | +49.5% | 0.00% | -100.0% |
| Q3 2022 | $3,000 | +200.0% | 3,084 | +869.8% | 0.00% | – |
| Q2 2022 | $1,000 | – | 318 | +77.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 179 | -94.5% | 0.00% | -100.0% |
| Q4 2021 | $12,000 | -73.3% | 3,275 | -62.2% | 0.00% | -83.3% |
| Q3 2021 | $45,000 | +60.7% | 8,667 | +31.1% | 0.01% | +100.0% |
| Q2 2021 | $28,000 | +211.1% | 6,610 | +310.6% | 0.01% | +200.0% |
| Q1 2021 | $9,000 | 0.0% | 1,610 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | -30.8% | 1,610 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $13,000 | -68.3% | 1,610 | -60.3% | 0.00% | -66.7% |
| Q2 2020 | $41,000 | +1266.7% | 4,058 | +332.6% | 0.01% | +1100.0% |
| Q1 2020 | $3,000 | – | 938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
| Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
| NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
| PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
| GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
| Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
| Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
| Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
| AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
| Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |